# Atomoxetine to Treat Adolescents With Coexisting Alcohol and Other Substance Use Disorder and ADHD

> **NCT00029614** · PHASE2 · COMPLETED · sponsor: **University of Pittsburgh** · enrollment: 24 (estimated)

## Conditions studied

- Substance Use Disorders
- Attention Deficit Hyperactivity Disorder

## Interventions

- **DRUG:** Atomoxetine

## Key facts

- **NCT ID:** NCT00029614
- **Lead sponsor:** University of Pittsburgh
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** —
- **Final completion:** 2007-07
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2010-04-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00029614

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00029614, "Atomoxetine to Treat Adolescents With Coexisting Alcohol and Other Substance Use Disorder and ADHD". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00029614. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*